Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
Status:
Not yet recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
The study is an investigator-sponsored, prospective, multicenter, randomized, open-label
study designed to compare efficacy and safety between bivalirudin and heparin in patients
with non-valvular atrial fibrillation undergoing percutaneous left atrial appendage
occlusion.